11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management...(for LCA-Vision from March 2000 to June 2...),Health

Date:12/4/2008

for LCA-Vision from March 2000 to June 2008. He came to LCA-Vision from Pease Industries; a manufacturing company based in Fairfield, Ohio, where he served as Vice President, Finance from 1991 to February 2000. Prior to 1991, Mr. Buckey served as Chief Financial Officer of the Hilltop Companies, a contract laboratory research firm and as a senior manager with Ernst & Young's Great Lakes Consulting Group. While at Ernst & Young, he served as acting Chief Financial Officer of a start-up laser surgery management company which was the predecessor of LCA-Vision. Mr. Buckey holds a B.S. in Applied Science from Miami University and holds an M.B.A in Finance from the Wharton School, University of Pennsylvania. He is a Certified Public Accountant.

                                                        Stephen N. Joffe
                                                          Craig P. Joffe
                                                          Alan H. Buckey
                                                    9560 Montgomery Road
                                                    Cincinnati, OH 45242

    VIA EMAIL & CERTIFIED MAIL

    December 4, 2008

    Mr. E. Anthony Woods, Chairman of the Board
    LCA-Vision Inc.
    c/o LCA-Vision Inc.
    7840 Montgomery Road
    Cincinnati, Ohio 45236

Dear Tony:

As we have previously expressed to you, we are significant shareholders who feel financial, ethical, and reputational responsibilities to the Company and its shareholders to save LCA-Vision from its current path to self-destruction.

From the Board's lack of responsiveness to our initial discussions, to the recent promotion of Mike Celebrezze to CFO, to the adoption of the "poison pill" without shareholder approval, it became apparent to us that the Board may have outstanding questions or concerns about our genuine offer to help the Company
'/>"/>

SOURCE Steve Joffe Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. 11.4% Shareholders & Former Executive Management of LCA-Vision Express Shock and Disbelief at Recent Adoption of Poison Pill
2. Dynamics Research Corporation Awarded $11.4 Million Medical Healthcare Program Management Contract
3. Senator Norm Coleman Praised for Leading Successful Effort to Derail $11.4 Million Minnesota Medicare Cuts
4. NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder
5. The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders
6. Barr Shareholders Approve Pending Teva Acquisition
7. Cord Blood America Posts Letter to Shareholders: New Administrations Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders
8. Lees Pharmaceutical Kept Up the Rapid Pace of Growth; Profit Attributable to Shareholders Surged 176% in the Nine Months of 2008
9. MaxLife Fund Corp. declares dividends to shareholders of Preferred Shares
10. Westaim terminates reorganization agreement and cancels shareholders meeting
11. GeneThera - CHANGING DIRECTIONS - an Update to Shareholders